Zura Bio reports 97.2% of public warrants and 69% of private warrants tendered in exchange offer

Zura Bio Ltd

6,703,428 public warrants (~97.2%) and 4,080,580 private placement warrants (~69.0%) validly tendered; settlement expected by Aug 12, 2024.
Each tendered warrant exchanged for 0.30 Class A ordinary shares; remaining untendered warrants to be converted into 0.27 shares (10% less).
Consents received to amend warrant agreement; post-offer exchange will eliminate all outstanding IPO warrants.
Cantor Fitzgerald acted as dealer manager; Alliance Advisors as information agent.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.